Comprehensive Review of Adenoid Cystic Carcinoma: Pathogenesis, Diagnosis, and Emerging Therapeutic Approaches

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 14 | Issue : 03 | Page :
    By

    Gaurav Kumar Rajput,

  • Chitra Singh,

  • Megha Singh,

  • Khushi Chauhan,

  1. Assistant Professor, Department of Computing Sciences & IT, College of computing sciences & information technology, TMU moradabad, India
  2. M.Tech (Student), Department Biotechnology, Jaypee Institute of Information Technology, Noida, Uttar Pradesh, India
  3. M.Tech (Student), Department Biotechnology, Jaypee Institute of Information Technology, Noida, Uttar Pradesh, India
  4. M.Tech (Student), Department Biotechnology, Jaypee Institute of Information Technology, Noida, Uttar Pradesh, India

Abstract

Adenoid cystic carcinoma (ACC): an infrequent neoplasm, highly malignant, that develops mainly in the salivary glands with the potential to exist in any secretory glandular sites, including the lacrimal glands, breast, and respiratory tract. ACC usually has a benign initial course, but conversely, it is notoriously aggressive in behavior with high incidence of perineural invasion, local recurrence, and distant metastasis, mostly to the lungs. The tumor’s molecular features are characterized by recurrent MYB-NFIB fusion gene aberrations, aberrations in the regulation of the PI3K/AKT/mTOR and Wnt/β-catenin pathways, and other epigenetic changes driving oncogenesis. As a result, major advancements in diagnosis, including multiparametric imaging, next-generation sequencing (NGS), and immunohistochemical profiling, have facilitated the early detection and molecular subclassification. Although surgical resection with negative margins remains the gold standard treatment, the infiltrative and neurotropic behavior of ACC often results in incompletely excised tumors, which could lead to a high recurrence rate. IMRT, CIRT, and SRS are being developed as effective adjuncts to surgery; however, cytotoxic chemotherapy remains almost entirely ineffective owing mainly to inherent tumor-resistance mechanisms. Here we present new options being investigated as part of targeted molecular therapies, such as TKIs, inhibitors of the NOTCH pathway, and PD-1/PD-L1 immune checkpoint blockade. AI and machine learning are revolutionizing genomic analysis and personalized medicine-oriented applications that further refine treatment stratification and prognostic modeling. Due to the heterogeneous and complex nature of ACC, a multimodal precision oncology-based approach is, therefore, very much warranted for improving clinical outcomes. This review addresses the molecular pathogenesis understanding, simultaneous advances in diagnostic technologies, and innovative therapeutic paradigms of ACC, all together leading toward improved prognosis and personalized management.

Keywords: Adenoid Cystic Carcinoma, MYB-NFIB Fusion, Perineural Invasion, Targeted Therapy, Immunotherapy, Tyrosine Kinase Inhibitors, PI3K/AKT/mTOR Pathway, Epigenetic Modifications, Next-Generation Sequencing, Artificial Intelligence.

[This article belongs to Research and Reviews: Journal of Oncology and Hematology ]

How to cite this article:
Gaurav Kumar Rajput, Chitra Singh, Megha Singh, Khushi Chauhan. Comprehensive Review of Adenoid Cystic Carcinoma: Pathogenesis, Diagnosis, and Emerging Therapeutic Approaches. Research and Reviews: Journal of Oncology and Hematology. 2025; 14(03):-.
How to cite this URL:
Gaurav Kumar Rajput, Chitra Singh, Megha Singh, Khushi Chauhan. Comprehensive Review of Adenoid Cystic Carcinoma: Pathogenesis, Diagnosis, and Emerging Therapeutic Approaches. Research and Reviews: Journal of Oncology and Hematology. 2025; 14(03):-. Available from: https://journals.stmjournals.com/rrjooh/article=2025/view=224957


References

  1. Jaso, J., & Malhotra, R. (2011). Adenoid cystic carcinoma. Archives of pathology & laboratory medicine, 135(4), 511-515.
  2. Coca-Pelaz, A., Rodrigo, J. P., Bradley, P. J., Vander Poorten, V., Triantafyllou, A., Hunt,
  3. L., … & Ferlito, A. (2015). Adenoid cystic carcinoma of the head and neck–An update. Oral oncology, 51(7), 652-661.
  4. Khan, A. J., DiGiovanna, M. P., Ross, D. A., Sasaki, C. T., Carter, D., Son, Y. H., & Haffty,
  5. G. (2001). Adenoid cystic carcinoma: a retrospective clinical review. International journal of cancer, 96(3), 149-158.
  6. Ro, J. Y., Silva, E. G., & Gallager, H. S. (1987). Adenoid cystic carcinoma of the breast. Human pathology, 18(12), 1276-1281.
  7. Kokemueller, H., Eckardt, A., Brachvogel, P., & Hausamen, J. E. (2004). Adenoid cystic carcinoma of the head and neck—a 20 years’ experience. International sjournal of oral and maxillofacial surgery, 33(1), 25-31.
  8. Maziak, D. E., Todd, T. R., Keshavjee, S. H., Winton, T. L., Van Nostrand, P., & Pearson,
  9. G. (1996). Adenoid cystic carcinoma of the airway: thirty-two-year experience. The journal of thoracic and cardiovascular surgery, 112(6), 1522-1532.
  10. Castelnuovo, P., & Turri-Zanoni, M. (2020). Adenoid cystic carcinoma. Anterior Skull Base Tumors, 84, 197-209.
  11. Gondivkar, S. M., Gadbail, A. R., Chole, R., & Parikh, R. V. (2011). Adenoid cystic carcinoma: a rare clinical entity and literature review. Oral oncology, 47(4), 231-236.
  12. Kim, K. H., Sung, M. W., Chung, P. S., Rhee, C. S., Park, C. I., & Kim, W. H. (1994).
  13. Adenoid cystic carcinoma of the head and neck. Archives of Otolaryngology–Head & Neck Surgery, 120(7), 721-726.
  14. Balamucki, C. J., Amdur, R. J., Werning, J. W., Vaysberg, M., Morris, C. G., Kirwan, J. M., & Mendenhall, W. M. (2012). Adenoid cystic carcinoma of the head and neck. American journal of otolaryngology, 33(5), 510-518.
  15. Ho, A. S., Kannan, K., Roy, D. M., Morris, L. G., Ganly, I., Katabi, N., … & Chan, T. A. (2013). The mutational landscape of adenoid cystic carcinoma. Nature genetics, 45(7), 791-798.
  16. Spiro, R. H., & Huvos, A. G. (1992). Stage means more than grade in adenoid cystic carcinoma. The American journal of surgery, 164(6), 623-628.
  17. Spiro, R. H., Huvos, A. G., & Strong, E. W. (1979). Adenoid cystic carcinoma: factors influencing survival. American journal of surgery, 138(4), 579-583.
  18. Dillon, P. M., Chakraborty, S., Moskaluk, C. A., Joshi, P. J., & Thomas, C. Y. (2016). Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials. Head & neck, 38(4), 620-627.
  19. Moskaluk, C. A. (2013). Adenoid cystic carcinoma: clinical and molecular features. Head and neck pathology, 7, 17-22.
  20. Sur, R. K., Donde, B., Levin, V., Pacella, J., Kotzen, J., Cooper, K., & Hale, M. (1997). Adenoid cystic carcinoma of the salivary glands: a review of 10 years. The Laryngoscope, 107(9), 1276-1280.
  21. Vikram, B., Strong, E. W., Shah, J. P., & Spiro, R. H. (1984). Radiation therapy in adenoid- cystic carcinoma. International Journal of Radiation Oncology* Biology* Physics, 10(2), 221-223.
  22. Miyai, K., Schwartz, M. R., Divatia, M. K., Anton, R. C., Park, Y. W., Ayala, A. G., & Ro,
  23. Y. (2014). Adenoid cystic carcinoma of breast: Recent advances. World Journal of Clinical Cases: WJCC, 2(12), 732.
  24. Chummun, S., McLean, N. R., Kelly, C. G., Dawes, P. J. D. K., Fellows, S., Meikle, D., & Soames, J. V. (2001). Adenoid cystic carcinoma of the head and neck. British journal of plastic surgery, 54(6), 476-480.
  25. Seethala, R. R., Hunt, J. L., Baloch, Z. W., LiVolsi, V. A., & Barnes, E. L. (2007). Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. The American journal of surgical pathology, 31(11), 1683-1694.
  26. Jones, A. S., Hamilton, J. W., Rowley, H., Husband, D., & Helliwell, T. R. (1997). Adenoid cystic carcinoma of the head and neck. Clinical Otolaryngology & Allied Sciences, 22(5), 434-443.
  27. Fordice, J., Kershaw, C., El-Naggar, A., & Goepfert, H. (1999). Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Archives of Otolaryngology– Head & Neck Surgery, 125(2), 149-152.
  28. Fang, Y., Peng, Z., Wang, Y., Gao, K., Liu, Y., Fan, R., … & Jiang, W. (2022). Current opinions on diagnosis and treatment of adenoid cystic carcinoma. Oral Oncology, 130, 105945.
  29. Eby, L. S., Johnson, D. S., & Baker, H. W. (1972). Adenoid cystic carcinoma of the head and neck. Cancer, 29(5), 1160-1168.
  30. Glazebrook, K. N., Reynolds, C., Smith, R. L., Gimenez, E. I., & Boughey, J. C. (2010). Adenoid cystic carcinoma of the breast. American Journal of Roentgenology, 194(5), 1391- 1396.
  31. Ferry, J. A., & Scully, R. E. (1988). “Adenoid cystic” carcinoma and adenoid basal carcinoma of the uterine cervix: a study of 28 cases. The American journal of surgical pathology, 12(2), 134-144.
  32. Azumi, N., & Battifora, H. (1987). The cellular composition of adenoid cystic carcinoma. An immunohistochemical study. Cancer, 60(7), 1589-1598.
  33. Arpino, G., Clark, G. M., Mohsin, S., Bardou, V. J., & Elledge, R. M. (2002). Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. Cancer, 94(8), 2119-2127.
  34. da Cruz Perez, D. E., de Abreu Alves, F., Nishimoto, I. N., De Almeida, O. P., & Kowalski,
  35. P. (2006). Prognostic factors in head and neck adenoid cystic carcinoma. Oral oncology, 42(2), 139-146.
  36. Szanto, P. A., Luna, M. A., Tortoledo, M. E., & White, R. A. (1984). Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer, 54(6), 1062-1069.
  37. Bradley, P. J. (2004). Adenoid cystic carcinoma of the head and neck: a review. Current opinion in otolaryngology & head and neck surgery, 12(2), 127-132.
  38. Rapidis, A. D., Givalos, N., Gakiopoulou, H., Faratzis, G., Stavrianos, S. D., Vilos, G. A.,
  39. … & Patsouris,  E. (2005). Adenoid cystic carcinoma  of  the  head  and neck.:
  40. Clinicopathological analysis of 23 patients and review of the literature. Oral oncology, 41(3), 328-335.
  41. Esmaeli, B., Ahmadi, M. A., Youssef, A., Diba, R., Amato, M., Myers, J. N., … & El- Naggar, A. (2004). Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plastic & Reconstructive Surgery, 20(1), 22-26.
  42. Azar, T., Abdul‐Karim, F. W., & Tucker, H. M. (1998). Adenoid cystic carcinoma of the
  43. trachea. The Laryngoscope, 108(9), 1297-1300.
  44. Nagao, T., Gaffey, T. A., Serizawa, H., Sugano, I., Ishida, Y., Yamazaki, K., … & Lewis,
  45. E. (2003). Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Modern pathology, 16(12), 1265-1272.
  46. Nagao, T., Gaffey, T. A., Serizawa, H., Sugano, I., Ishida, Y., Yamazaki, K., … & Lewis,
  47. E. (2003). Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Modern pathology, 16(12), 1265-1272.
  48. Naylor, E., Sarkar, P., Perlis, C. S., Giri, D., Gnepp, D. R., & Robinson-Bostom, L. (2008). Primary cutaneous adenoid cystic carcinoma. Journal of the American Academy of Dermatology, 58(4), 636-641.
  49. Conley, J., & Dingman, D. L. (1974). Adenoid cystic carcinoma in the head and neck (cylindroma). Archives of otolaryngology, 100(2), 81-90.
  50. Ghabach, B., Anderson, W. F., Curtis, R. E., Huycke, M. M., Lavigne, J. A., & Dores, G.
  51. (2010). Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Research, 12, 1-9.
  52. Lee, R. H., Wai, K. C., Chan, J. W., Ha, P. K., & Kang, H. (2022). Approaches to the management of metastatic adenoid cystic carcinoma. Cancers, 14(22), 5698.
  53. Marchiano, E., Chin, O. Y., Fang, C. H., Park, R. C., Baredes, S., & Eloy, J. A. (2016). Laryngeal adenoid cystic carcinoma: a systematic review. Otolaryngology–Head and Neck Surgery, 154(3), 433-439.
Regular Issue Subscription Review Article
Volume 14
Issue 03
Received 04/07/2025
Accepted 20/07/2025
Published 27/08/2025
Publication Time 54 Days
175

Login


My IP

PlumX Metrics